Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations
Canadian Journal of Urology · Jeanny B. Aragon-Ching, Ravi A. Madan · 2026
- EnglishRead in your language
- CitedEvery fact sourced
- Ad-freeNo ads, no tracking
Quick facts
Questions
- Who wrote Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations?
- Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations was written by Jeanny B. Aragon-Ching, Ravi A. Madan.
- When was Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations first published?
- Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations was first published in 2026.
Sources
Last updated · facts checked 2 November 2026
Cite this page
"Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-cju-2026-082958. Retrieved 14 November 2026.
Open-access publication. Read it free at the publisher: https://doi.org/10.32604/cju.2026.082958.